These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29626043)

  • 1. HIV-1 disease progression in immune-competent HIV-1-infected and breastfeeding mothers participating in the ANRS 12174 clinical trial in Burkina Faso, South Africa, Uganda and Zambia: a cohort study.
    Somé EN; Engebretsen IMS; Nagot N; Meda NY; Vallo R; Kankasa C; Tumwine JK; Singata-Madliki M; Harper K; Hofmeyr GJ; Van de Perre P; Tylleskär T;
    BMJ Open; 2018 Apr; 8(4):e019239. PubMed ID: 29626043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in body mass index and hemoglobin concentration in breastfeeding women living with HIV with a CD4 count over 350: Results from 4 African countries (The ANRS 12174 trial).
    Somé EN; Engebretsen IMS; Nagot N; Meda NY; Vallo R; Kankasa C; Tumwine JK; Singata M; Hofmeyr JG; Van de Perre P; Tylleskär T;
    PLoS One; 2017; 12(5):e0177259. PubMed ID: 28486519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breastfeeding patterns and its determinants among mothers living with Human Immuno-deficiency Virus -1 in four African countries participating in the ANRS 12174 trial.
    Somé EN; Engebretsen IMS; Nagot N; Meda N; Lombard C; Vallo R; Peries M; Kankasa C; Tumwine JK; Hofmeyr GJ; Singata M; Harper K; Van De Perre P; Tylleskar T;
    Int Breastfeed J; 2016; 12():22. PubMed ID: 28469697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial.
    Nagot N; Kankasa C; Tumwine JK; Meda N; Hofmeyr GJ; Vallo R; Mwiya M; Kwagala M; Traore H; Sunday A; Singata M; Siuluta C; Some E; Rutagwera D; Neboua D; Ndeezi G; Jackson D; Maréchal V; Neveu D; Engebretsen IMS; Lombard C; Blanche S; Sommerfelt H; Rekacewicz C; Tylleskär T; Van de Perre P;
    Lancet; 2016 Feb; 387(10018):566-573. PubMed ID: 26603917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determinants of low birth weight among newborns to HIV-infected mothers not eligible for antiretroviral treatment in Africa].
    Traore H; Meda N; Nagot N; Somé E; Neboua D; Kankasa C; Hofmeyr J; Tumwine J; Vallo R; Ye D; Tylleskar T; Van de Perre P
    Rev Epidemiol Sante Publique; 2013 Oct; 61(5):413-20. PubMed ID: 24016738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lopinavir/Ritonavir versus Lamivudine peri-exposure prophylaxis to prevent HIV-1 transmission by breastfeeding: the PROMISE-PEP trial Protocol ANRS 12174.
    Nagot N; Kankasa C; Meda N; Hofmeyr J; Nikodem C; Tumwine JK; Karamagi C; Sommerfelt H; Neveu D; Tylleskär T; Van de Perre P;
    BMC Infect Dis; 2012 Oct; 12():246. PubMed ID: 23039034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and challenges of a large HIV prevention clinical study on mother-to-child transmission: ANRS 12397 PROMISE-EPI study in Zambia and Burkina Faso.
    Mennecier A; Kankasa C; Fao P; Moles JP; Eymard-Duvernay S; Mwiya M; Kania D; Chunda-Liyoka C; Sakana L; Rutagwera D; Tassembedo S; Wilfred-Tonga MM; Mosqueira B; Tylleskär T; Nagot N; Van de Perre P;
    Contemp Clin Trials; 2021 Jun; 105():106402. PubMed ID: 33872801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimised prevention of postnatal HIV transmission in Zambia and Burkina Faso (PROMISE-EPI): a phase 3, open-label, randomised controlled trial.
    Kankasa C; Mennecier A; Sakana BLD; Molès JP; Mwiya M; Chunda-Liyoka C; D'Ottavi M; Tassembedo S; Wilfred-Tonga MM; Fao P; Rutagwera D; Matoka B; Kania D; Taofiki OA; Tylleskär T; Van de Perre P; Nagot N;
    Lancet; 2024 Apr; 403(10434):1362-1371. PubMed ID: 38484756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exclusive breastfeeding promotion and neuropsychological outcomes in 5-8 year old children from Uganda and Burkina Faso: Results from the PROMISE EBF cluster randomized trial.
    Tumwine JK; Nankabirwa V; Diallo HA; Engebretsen IMS; Ndeezi G; Bangirana P; Sanou AS; Kashala-Abotnes E; Boivin M; Giordani B; Elgen IB; Holding P; Kakooza-Mwesige A; Skylstad V; Nalugya J; Tylleskar T; Meda N
    PLoS One; 2018; 13(2):e0191001. PubMed ID: 29474479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exclusive breastfeeding promotion by peer counsellors in sub-Saharan Africa (PROMISE-EBF): a cluster-randomised trial.
    Tylleskär T; Jackson D; Meda N; Engebretsen IM; Chopra M; Diallo AH; Doherty T; Ekström EC; Fadnes LT; Goga A; Kankasa C; Klungsøyr JI; Lombard C; Nankabirwa V; Nankunda JK; Van de Perre P; Sanders D; Shanmugam R; Sommerfelt H; Wamani H; Tumwine JK;
    Lancet; 2011 Jul; 378(9789):420-7. PubMed ID: 21752462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.
    Ciaffi L; Koulla-Shiro S; Sawadogo AB; Ndour CT; Eymard-Duvernay S; Mbouyap PR; Ayangma L; Zoungrana J; Gueye NFN; Diallo M; Izard S; Bado G; Kane CT; Aghokeng AF; Peeters M; Girard PM; Le Moing V; Reynes J; Delaporte E;
    Lancet HIV; 2017 Sep; 4(9):e384-e392. PubMed ID: 28566227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d'Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial.
    Dahourou DL; Amorissani-Folquet M; Malateste K; Amani-Bosse C; Coulibaly M; Seguin-Devaux C; Toni T; Ouédraogo R; Blanche S; Yonaba C; Eboua F; Lepage P; Avit D; Ouédraogo S; Van de Perre P; N'Gbeche S; Kalmogho A; Salamon R; Meda N; Timité-Konan M; Leroy V;
    BMC Med; 2017 Apr; 15(1):85. PubMed ID: 28434406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diversity of risk of mother-to-child HIV-1 transmission according to feeding practices, CD4 cell count, and haemoglobin concentration in a South African cohort.
    Tournoud M; Ecochard R; Kuhn L; Coutsoudis A
    Trop Med Int Health; 2008 Mar; 13(3):310-8. PubMed ID: 18397394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early infant feeding practices in three African countries: the PROMISE-EBF trial promoting exclusive breastfeeding by peer counsellors.
    Engebretsen IM; Nankabirwa V; Doherty T; Diallo AH; Nankunda J; Fadnes LT; Ekström EC; Ramokolo V; Meda N; Sommerfelt H; Jackson D; Tylleskär T; Tumwine JK;
    Int Breastfeed J; 2014; 9():19. PubMed ID: 25784955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth, clinical and neurodevelopmental outcomes at school age are similar for children who received 1-year lamivudine or lopinavir/ritonavir HIV prophylaxis in early life.
    Nagot N; Singata-Madliki M; Cournil A; Nalugya J; Tassembedo S; Quillet C; Tonga MW; Tumwine J; Meda N; Kankasa C; Mwiya M; Bangirana P; Peries M; Batting J; Engebretsen IMS; Tylleskär T; Perre PV; Ndeezi G; Molès JP
    Sci Rep; 2021 Feb; 11(1):3173. PubMed ID: 33542437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial.
    Petra Study Team
    Lancet; 2002 Apr; 359(9313):1178-86. PubMed ID: 11955535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Cytomegalovirus Secretion and Risks of Infant Infection by Breastfeeding Duration From Maternal Human Immunodeficiency Virus Positive Compared to Negative Mothers in Sub-Saharan Africa.
    Musonda KG; Nyonda M; Filteau S; Kasonka L; Monze M; Gompels UA
    J Pediatric Infect Dis Soc; 2016 Jun; 5(2):138-46. PubMed ID: 27103488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 disease progression in breast-feeding and formula-feeding mothers: a prospective 2-year comparison of T cell subsets, HIV-1 RNA levels, and mortality.
    Otieno PA; Brown ER; Mbori-Ngacha DA; Nduati RW; Farquhar C; Obimbo EM; Bosire RK; Emery S; Overbaugh J; Richardson BA; John-Stewart GC
    J Infect Dis; 2007 Jan; 195(2):220-9. PubMed ID: 17191167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.